Rexahn Pharmaceuticals (RNN) Prices Equity Offering

Rexahn Pharmaceuticals (NYSE: RNN) priced an underwritten public offering of 19,130,435 shares of its common stock and warrants exercisable for up to 10,521,739 additional shares at $0.33 per fixed combination of shares and warrants for gross proceeds of approximately $6.3 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company and excluding the exercise of any warrants and any exercise of the underwriters’ over-allotment option. Each fixed combination will consist of one share and a warrant to purchase up to 0.55 of a share. The warrants will have an exercise price of $0.472 per share and a 5-year term

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Columbus Circle Capital Corp. III closes $230M IPO on Nasdaq
• Discovery Energy Metals plans private placement of up to $1.25M
• Ideal Power (IPWR) files $75M mixed shelf